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Diabetes and carbohydrate intolerance can occur in pancreatitis. Although one-half of pa-
tients with acute pancreatitis will have some evidence of glucose intolerance during their acute
illness, few will require insulin administration on either a short- or long-term basis. The
diabetes seen in acute pancreatitis is likely due to a combination of factors, including alerted
insulin secretion, increased glucagon release, and decreased glucose utilization by the liver and
peripheral tissue. Chronic pancreatitis is often associated with diabetes mellitus, with the in-
cidence as high as 70 percent when pancreatic calcification is present. These patients tend to be
very sensitive to the effects ofinsulin and hypoglycemia. This is probably secondary to concur-
rent hepatic disease, malnutrition, and a relative decrease in glucagon reserves. The diabetes
seen in chronic pancreatitis is associated with decreased insulin production. Finally, although
the endocrine pancreas may influence the exocrine gland through a portal system, primary
diabetes mellitus probably does not result in clinically significant alterations in pancreatic exo-
crine function.
Diabetes mellitus and glucose intolerance are recognized complications of acute
and chronic pancreatitis [1]. Multiple factors including widespread alterations in
neurohumoral function and islet destruction are likely of importance in the genesis
of the diabetes mellitus that develops in this setting. This review will examine some
of those factors and attempt to relate them to the natural history of these disease
states.
DIABETES MELLITUS AND ACUTE PANCREATITIS
Clinical Presentation
Although 30 percent of patients with severe acute pancreatitis will demonstrate
glycosuria and 50 percent an elevated blood sugar level [2], the diabetes in this set-
ting is usually self-limiting and resolves in parallel to the pancreatitis [3]. Occa-
sionally, patients with acute pancreatitis do develop diabetic ketoacidosis and
require insulin therapy [2]. These patients appear to be susceptible to hypoglycemia,
so insulin should be administered cautiously [2]. A small percentage (1-2 percent) of
patients will remain diabetic after a single attack of pancreatitis [4].
Pathogenesis
The diabetes mellitus seen with acute pancreatitis is probably multifactorial and
includes pancreatic islet destruction and a "hyperglycemic" hormonal milieu.
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All rights of reproduction in any form reserved.Since the endocrine and exocrine pancreas reside in the same anatomic domain, it
is not surprising that factors that result in widespread cellular and vascular damage
[5] should result in injury to both portions of the organ. A decrease in islet function
appears to be present in acute pancreatitis, although some controversy still exists.
Johansen and Ornsholt [4] identified decreased insulin secretion in acute pan-
creatitis. In contrast, Donowitz et al. [6] find an increase in basal and alanine-
stimulated insulin levels in patients with initial acute attacks of pancreatitis. In the
latter study, insulin levels from patients with recurrent acute attacks of pancreatitis
did not differ from control subjects. Recently, Seligson et al. [7] examined patients
with pancreatitis and demonstrated a decrease in the response of C-peptide secretion
to oral glucose. Although the differences in these studies may be related to the
method used to study insulin secretion, the patient population and the timing of the
study, in some patients with acute pancreatitis decreased insulin secretion appears to
be a factor in the development of diabetes.
Glucagon reserves in the pancreas appear to surpass those of insulin. Early in-
vestigation demonstrated that the diabetes resulting from pancreatic resection was
more easily controlled if the entire pancreas was removed [8]. Yasugi et al. [9]
demonstrated that, following pancreatic resection, glucagon secretion can be
preserved at a point at which insulin secretion diminishes. Donowitz et al. [6]
demonstrated a dramatic increase in basal and alanine-stimulated plasma glucagon
levels during the initial attacks of pancreatitis. Therefore, although diabetes and
diabetic ketoacidosis may occur in the absence of hyperglucagonemia [10], it ap-
pears to be of importance in the development of the diabetic state in acute pan-
creatitis.
Elevations in blood glucose levels can arise from several primary pathogenic
sources as recently outlined by DeFronzo et al. [11]. These include a decrease in in-
sulin release, a decrease in the hepatic uptake of glucose, and an alteration in the
peripheral utilization of glucose. Having commented on insulin secretion in acute
pancreatitis, I would like to focus on glucose utilization. Acute pancreatitis is often
characterized by hypovolumemia and shock; a setting recognized to be associated
with increased adrenergic secretion. Epinephrine, produced as part of the "stress"
response, has been shown to inhibit insulin secretion in vivo [12]. Recently, Deibert
and DeFronzo [13] have shown, in man under euglycemic conditions, that epi-
nephrine also acts to block the effect of insulin on hepatic glucose metabolism and
peripheral glucose uptake. Thus, an additional factor in the development of the
diabetes seen in acute pancreatitis may be decreased glucose utilization.
DIABETES MELLITUS AND CHRONIC PANCREATITIS
Clinical Presentation
Diabetes mellitus is a well-recognized complication of chronic pancreatitis. Overt
diabetes or glucose intolerance can precede the onset of pancreatic calcification in
chronic pancreatitis and was observed in 30 percent and 20 percent of patients,
respectively, in one series [2]. When pancreatic calcifications are present, that group
observed overt diabetes in 70 percent of patients, and an additional 20 percent
demonstrated glucose intolerance. Diabetes often precedes steatorrhea in chronic
pancreatitis. This finding is not unexpected since the apparent pancreatic exocrine
reserve is threefold greater than the endocrine reserve as measured in experimental
pancreatic resection [9].
Several features of the diabetes mellitus associated with pancreatitis are worthy of
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consideration. These patients appear to be very sensitive to insulin and readily ex-
perience hypoglycemia [14]. Linde et al. [15] noted hypoglycemic episodes in 14 of
18 insulin-treated patients and, in three, it was believed to be the cause of death.
There are several factors which likely contribute to this insulin sensitivity. First,
these patients often abuse ethanol and hepatic gluconeogenesis may be directly in-
hibited [16]. Second, these patients frequently have a poor caloric intake. Third,
some [151, though not all [6], patients with chronic pancreatitis have been reported
to have low plasma glucagon levels. Since glucagon appears to be important in the
maintenance of blood glucose levels at least in part through the stimulation of
hepatic glucose production, it is probably important in the development of
hypoglycemia. Furthermore, patients with chronic liver disease, a condition often
associated with chronic pancreatitis, appear to be glucagon-resistant relative to
hepatic glucose production [17]. This tends to place them in a precarious situation
relative to the development of hypoglycemia in that they are both underproducing
(chronic pancreatitis) and resistant to (chronic liver disease) glucagon.
A potential benefit of the decreased glucagon levels in chronic pancreatitis is that
it may prevent prolonged episodes of hyperglycemia. In addition, glucagon ap-
parently accelerates ketonemia [10], presumably by reducing the liver's ability to
convert free fatty acids to ketoacids and thus may be an important factor in the ap-
parently low incidence of diabetic ketoacidosis in chronic pancreatitis.
The vascular complications seen with the diabetes mellitus associated with chronic
pancreatitis are said to occur infrequently. This statement is based, in large part, on
the observations of Sevel et al. [18] relative to the development of diabetic
retinopathy in chronic pancreatitis (incidence of retinopathy 7.4 percent in chronic
pancreatitis). Although this study is intriguing, further investigation is needed to
determine if the natural history of vascular disease in this form of diabetes mellitus
differs from that seen in other diabetics.
Pathogenesis
The diabetes seen in chronic pancreatitis is multifactoral and likely includes
decreased insulin release [19] and a relative preservation of glucagon over insulin
reserves [9]. This decreased insulin secretion is probably secondary to progressive
islet destruction through recurrent bouts of pancreatitis, or a direct toxic effect of
alcohol on islet cells similar to that shown for the exocrine pancreas [20]. The
relevance of the-observation that patients with chronic pancreatitis have altered
basal and meal-stimulated levels of a number of gastrointestinal hormones to the
diabetic state is unknown [21].
THE EFFECTS OF DIABETES ON EXOCRINE PANCREATIC FUNCTION
How can the endocrine pancreas influence the exocrine portion ofthe organ? The
endocrine pancreas is connected to the exocrine pancreas through a portal system.
This potentially allows high concentrations of islet peptides to reach pancreatic
acinar cells [22].
Insulin has been demonstrated to specifically bind to pancreatic acinar cells [231
and to stimulate protein phosphorylation in that tissue [24]. In addition, protein
synthesis by pancreatic acini is diminished in diabetic mice [23-25]. In vivo ex-
periments in diabetic mice demonstrate that amylase secretion in response to
cholecyslokinin is diminished, although the mechanism is unclear [26]. Whether
these alterations in the exocrine pancreatic function in diabetes are secondary to a
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decrease in insulin secretion or other factors such as decreased cholinergic input
secondary to an autonomic neuropathy is unclear.
Alterations in exocrine pancreatic function have been studied exclusively in
juvenile-onset diabetes. Although a decrease in amylase secretion is generally
described [27], a diminished secretion of proteases has also been noted [28]. In spite
of the fact that these studies suggest a degree of pancreatic exocrine dysfunction in
some patients with primary diabetes, it appears unlikely that it is enough ofa change
to result in malabsorption.
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